InnoCare Pharma Limited
INCPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,747,243 | $28,311,316 | $42,502,807 | $38,428,309 |
| - Cash | $957,529 | $7,056,195 | $7,008,087 | $6,222,626 |
| + Debt | $233,805 | $1,538,246 | $1,544,842 | $1,271,545 |
| Enterprise Value | $5,023,519 | $22,793,368 | $37,039,562 | $33,477,228 |
| Revenue | $53,880 | $350,171 | $381,263 | $311,700 |
| % Growth | -84.6% | -8.2% | 22.3% | – |
| Gross Profit | $47,078 | $309,524 | $345,197 | $271,287 |
| % Margin | 87.4% | 88.4% | 90.5% | 87% |
| EBITDA | -$2,639 | -$88,695 | -$3,259 | -$121,475 |
| % Margin | -4.9% | -25.3% | -0.9% | -39% |
| Net Income | -$4,817 | -$48,059 | $17,968 | -$165,223 |
| % Margin | -8.9% | -13.7% | 4.7% | -53% |
| EPS Diluted | -0.003 | -0.04 | 0.01 | -0.1 |
| % Growth | 93.2% | -496% | 110% | – |
| Operating Cash Flow | -$114 | -$118,341 | $56,524 | -$32,416 |
| Capital Expenditures | -$1,947 | -$9,873 | -$15,058 | -$6,961 |
| Free Cash Flow | -$2,061 | -$128,214 | $41,466 | -$39,377 |